Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. said Wednesday it received final Food and Drug Administration approval for its generic version of Zofran, which is used to prevent nausea and vomiting associated with cancer treatment.

The company's ondansetron hydrochloride tablets, in 4 mg, 8mg, 16 mg and 24 mg doses, were given a 180-day period of marketing exclusivity.

Zofran is manufactured by GlaxoSmithKline PLC.

NEWS ARCHIVES

2008

• September
• August
• July
• June
• May
• April
• March

2007

• April
• March
• February
• January

2006

• December
• November
• October
• September
• August
• July
• June
• May
• April
• March
• February
• January

2005

• December
• November
• October
• August
• June
• April
• March
• February

2004

• December

NEWSLETTER SIGNUP